Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B JOLLES

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
British Medical Journal|March 19, 2010
Kidney tumours in a child and her grandmotherA R BANHAM, B JOLLES
Biorheology|January 1, 1970
Vascular "action sites" and skin radiation reactionB Jolles, R G Harrison
The British Journal of Radiology|March 19, 2010
Optimal skin tolerance dose levelsB JOLLES, R G MITCHELL
Antisense & Nucleic Acid Drug Development|July 12, 2001
Best minimally modified antisense oligonucleotides according to cell nuclease activityT D Samani, B Jolles, A Laigle
Biochimie|January 1, 1973
[Protective effect of pyrodoxal phosphate on Pseudomonas fluorescens aminobutyrate aminotransferase]D Gomez de Gracia, B Jolles-Bergeret
British Medical Journal|February 14, 1970
Nasal cancer in the Northamptonshire boot and shoe industryE D Acheson, R H Cowdell, B Jolles
British Medical Journal|June 27, 1970
Nasal cancer in the shoe industryE D Acheson, R H Cowdell, B Jolles
British Journal of Cancer|July 1, 1973
Effects of the anticoagulant, degraded Carrageenan, on experimental tumour growthB Jolles, R G Harrison, E A Moore
Biophysical Chemistry|April 1, 1993
Evaluation of the structural modifications induced by mitomycin C on nucleic acidsB Jolles, A Laigle, J Liquier, et al.
Antisense & Nucleic Acid Drug Development|July 25, 2000
A cationic derivative of amphotericin B as a novel delivery system for antisense oligonucleotidesC Garcia-Chaumont, O Seksek, B Jolles, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
British Medical Journal|March 19, 2010
Kidney tumours in a child and her grandmotherA R BANHAM, B JOLLES
Biorheology|January 1, 1970
Vascular "action sites" and skin radiation reactionB Jolles, R G Harrison
The British Journal of Radiology|March 19, 2010
Optimal skin tolerance dose levelsB JOLLES, R G MITCHELL
Antisense & Nucleic Acid Drug Development|July 12, 2001
Best minimally modified antisense oligonucleotides according to cell nuclease activityT D Samani, B Jolles, A Laigle
Biochimie|January 1, 1973
[Protective effect of pyrodoxal phosphate on Pseudomonas fluorescens aminobutyrate aminotransferase]D Gomez de Gracia, B Jolles-Bergeret
British Medical Journal|February 14, 1970
Nasal cancer in the Northamptonshire boot and shoe industryE D Acheson, R H Cowdell, B Jolles
British Medical Journal|June 27, 1970
Nasal cancer in the shoe industryE D Acheson, R H Cowdell, B Jolles
British Journal of Cancer|July 1, 1973
Effects of the anticoagulant, degraded Carrageenan, on experimental tumour growthB Jolles, R G Harrison, E A Moore
Biophysical Chemistry|April 1, 1993
Evaluation of the structural modifications induced by mitomycin C on nucleic acidsB Jolles, A Laigle, J Liquier, et al.
Antisense & Nucleic Acid Drug Development|July 25, 2000
A cationic derivative of amphotericin B as a novel delivery system for antisense oligonucleotidesC Garcia-Chaumont, O Seksek, B Jolles, et al.
Pageof 3